Bryan H. Norman

1.9k total citations
49 papers, 1.4k citations indexed

About

Bryan H. Norman is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Bryan H. Norman has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Organic Chemistry, 20 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Bryan H. Norman's work include Drug Transport and Resistance Mechanisms (9 papers), Synthetic Organic Chemistry Methods (8 papers) and Estrogen and related hormone effects (8 papers). Bryan H. Norman is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Synthetic Organic Chemistry Methods (8 papers) and Estrogen and related hormone effects (8 papers). Bryan H. Norman collaborates with scholars based in United States and Canada. Bryan H. Norman's co-authors include Albert Padwa, Jeffrey A. Dodge, Julian S. Kroin, Timothy I. Richardson, Venkatesh Krishnan, Jeff S. McDermott, Anne H. Dantzig, Richard M. Schultz, Chris J. Vlahos and Jim D. Durbin and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Bryan H. Norman

48 papers receiving 1.4k citations

Peers

Bryan H. Norman

ONCOL

PHARM

GENET

Amaury Farce France

George W. Carter United States

E H Ulm United States

Hiroyuki Miyachi Japan

James B. Summers United States

Erich L. Grimm Canada

Ted W. Johnson United States

Jennifer J. Bouska United States

Wolfgang Albrecht Germany

Mark A. Winter United States

Amaury Farce France

Bryan H. Norman

775 ×1.2

935 ×1.7

263 ×0.9

ONCOL

186 ×0.9

PHARM

202 ×1.2

GENET

Citations per year, relative to Bryan H. Norman Bryan H. Norman (= 1×) peers Amaury Farce

Countries citing papers authored by Bryan H. Norman

Since Specialization

Citations

This map shows the geographic impact of Bryan H. Norman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan H. Norman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan H. Norman more than expected).

Fields of papers citing papers by Bryan H. Norman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan H. Norman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan H. Norman. The network helps show where Bryan H. Norman may publish in the future.

Co-authorship network of co-authors of Bryan H. Norman

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan H. Norman. A scholar is included among the top collaborators of Bryan H. Norman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan H. Norman. Bryan H. Norman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Domingo‐Fernándéz, Daniel, et al.. (2023). Exploring the known chemical space of the plant kingdom: insights into taxonomic patterns, knowledge gaps, and bioactive regions. Journal of Cheminformatics. 15(1). 107–107. 12 indexed citations

Norman, Bryan H.. (2020). Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies. Journal of Medicinal Chemistry. 63(20). 11397–11419. 78 indexed citations

Ho, Joseph D., Matthew R. Lee, Charles T. Rauch, et al.. (2020). Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP). Biochimica et Biophysica Acta (BBA) - General Subjects. 1865(2). 129800–129800. 17 indexed citations

Norman, Bryan H., Matthew J. Fisher, Boris A. Czeskis, et al.. (2018). Identification and Mitigation of Reactive Metabolites of 2-Aminoimidazole-Containing Microsomal Prostaglandin E Synthase-1 Inhibitors Terminated Due to Clinical Drug-Induced Liver Injury. Journal of Medicinal Chemistry. 61(5). 2041–2051. 22 indexed citations

Thirunavukkarasu, Kannan, Bo Tan, Craig Swearingen, et al.. (2016). Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis. Journal of Pharmacology and Experimental Therapeutics. 359(1). 207–214. 25 indexed citations

Chandrasekhar, S., Anita K. Harvey, M.G. Chambers, et al.. (2016). Identification and Characterization of Novel Microsomal Prostaglandin E Synthase-1 Inhibitors for Analgesia. Journal of Pharmacology and Experimental Therapeutics. 356(3). 635–644. 20 indexed citations

Thirunavukkarasu, Kannan, Craig Swearingen, J.L. Oskins, et al.. (2016). Identification and pharmacological characterization of a novel inhibitor of autotaxin in rodent models of joint pain. Osteoarthritis and Cartilage. 25(6). 935–942. 16 indexed citations

Norman, Bryan H., Andrew G. Geiser, M.G. Chambers, et al.. (2013). Selective RAR gamma antagonist LY2813631 protects against retinoid induced cartilage degradation in preclinical models of arthritis. Osteoarthritis and Cartilage. 21. S287–S288. 1 indexed citations

Richardson, Timothy I., Jeffrey A. Dodge, Yong Wang, et al.. (2007). Benzopyrans as selective estrogen receptor β agonists (SERBAs). Part 5: Combined A- and C-ring structure–activity relationship studies. Bioorganic & Medicinal Chemistry Letters. 17(20). 5563–5566. 31 indexed citations

10.

Richardson, Timothy I., Jeffrey A. Dodge, Gregory L. Durst, et al.. (2007). Benzopyrans as selective estrogen receptor β agonists (SERBAs). Part 3: Synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification. Bioorganic & Medicinal Chemistry Letters. 17(17). 4824–4828. 42 indexed citations

11.

Norman, Bryan H., Timothy I. Richardson, Jeffrey A. Dodge, et al.. (2007). Benzopyrans as selective estrogen receptor β agonists (SERBAs). Part 4: Functionalization of the benzopyran A-ring. Bioorganic & Medicinal Chemistry Letters. 17(18). 5082–5085. 36 indexed citations

12.

Richardson, Timothy I., Bryan H. Norman, Charles W. Lugar, et al.. (2007). Benzopyrans as selective estrogen receptor β agonists (SERBAs). Part 2: Structure–activity relationship studies on the benzopyran scaffold. Bioorganic & Medicinal Chemistry Letters. 17(13). 3570–3574. 30 indexed citations

13.

Norman, Bryan H., Peter A. Lander, Joseph M. Gruber, et al.. (2005). Cyclohexyl-linked tricyclic isoxazoles are potent and selective modulators of the multidrug resistance protein (MRP1). Bioorganic & Medicinal Chemistry Letters. 15(24). 5526–5530. 49 indexed citations

14.

Norman, Bryan H., Joseph M. Gruber, Sean P. Hollinshead, et al.. (2002). Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1). Bioorganic & Medicinal Chemistry Letters. 12(6). 883–886. 55 indexed citations

15.

Norman, Bryan H., Anne H. Dantzig, Julian S. Kroin, et al.. (1999). Reversal of resistance in multidrug resistance protein (MRP1)-overexpressing cells by LY329146. Bioorganic & Medicinal Chemistry Letters. 9(23). 3381–3386. 23 indexed citations

16.

Talley, John J., Stephen R. Bertenshaw, David Brown, et al.. (1999). 4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2). Medicinal Research Reviews. 19(3). 199–208. 32 indexed citations

17.

Starling, James J., Robert L. Shepard, Jin Cao, et al.. (1997). Pharmacological characterization of LY335979: A potent cyclopropyldibenzosuberane modulator of P-glycoprotein. Advances in Enzyme Regulation. 37. 335–347. 70 indexed citations

18.

Norman, Bryan H. & Julian S. Kroin. (1995). Stereoselective synthesis of novel methylene ether dipeptide isosteres. Tetrahedron Letters. 36(24). 4151–4154. 4 indexed citations

19.

Bertenshaw, Stephen R., Roland S. Rogers, Michael Stern, et al.. (1993). Phosphorus-containing inhibitors of endothelin converting enzyme: effects of the electronic nature of phosphorus on inhibitor potency. Journal of Medicinal Chemistry. 36(1). 173–176. 26 indexed citations

20.

Padwa, Albert & Bryan H. Norman. (1990). A [4 + 1] annulation approach to nitrogen heterocycles using 2,3-bis(phenylsulfonyl)-1,3-butadiene and primary amines. The Journal of Organic Chemistry. 55(16). 4801–4807. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact